Skip to main content

and
  1. No Access

    Article

    RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation

    Inflammation is a complex biological host reaction to tissue damage, infection and trauma. Extensive study of the inflammatory response has led to the identification of several protein kinases that are essenti...

    Ke Yao, Sung-Young Lee, Cong Peng, Do Young Lim, Hiroyuki Yamamoto, Joohyun Ryu in Oncogene (2018)

  2. Article

    Open Access

    Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

    Emerging and re-emerging RNA viruses occasionally cause epidemics and pandemics worldwide, such as the on-going outbreak of the novel coronavirus SARS-CoV-2. Herein, we identified two potent inhibitors of huma...

    Rui **ong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang in Protein & Cell (2020)

  3. Article

    Open Access

    Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

    In the original publication there are few errors in Figure 1. The correct Figure 1 is provided in this correction

    Rui **ong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang in Protein & Cell (2021)

  4. Article

    Open Access

    Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

    In the original publication the author’s name ‘Dimitri Lavillete’ is published incorrectly. The correct author name should be spelt as ‘Dimitri Lavillette’ is provided in this correction.

    Rui **ong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang in Protein & Cell (2022)